Clinical Trial Update: Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating molecular profiling-guided targeted therapy across advanced non-small cell lung cancer, small cell lung cancer, and thymic carcinomas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Thymic Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2023-04-11